Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study

2012 ◽  
Vol 17 (6) ◽  
pp. 844-857 ◽  
Author(s):  
T. Ostenfeld ◽  
A. Krishen ◽  
R.Y. Lai ◽  
J. Bullman ◽  
A.J. Baines ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document